Anti-Cyclin B1 antibody [Y106] (Ab32053)
CCNB, CCNB1, G2/mitotic-specific cyclin-B1
详细信息
特异性
This antibody is specific for Human cyclin B1. It does not cross-react with other cyclin family members.
背景信息
What is this antibody validated in? Anti-Cyclin B1 antibody [Y106] (ab32053) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples. What is the molecular weight of Cyclin B1? Anti-Cyclin B1 [Y106] (ab32053) specifically detects a band for Cyclin B1 (UniProt: P14635) at a molecular weight of 58kDa. Trusted by the scientific community Anti-Cyclin B1 [Y106] (ab32053) was first used in a scientific publication in 2006 and has been cited over 180 times in peer-reviewed journals. Specificity confirmed The specificity of Anti-Cyclin B1 antibody [Y106] (ab32053) has been confirmed by Western blot testing in CCNB1 Knockout HAP1 cells. Other related products We have a range of other formats of antibody clone [Y106] also available for your convenience: ab32053, Carrier free - ab156447, HRP - ab193977, PE - ab210615, Alexa Fluor® 555 - ab214381 Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (201)
The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.
转移性结直肠癌对 FOLFIRI 化疗产生耐药性的分子和功能图谱。
Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C.
Halorotetin B 是一种源自海洋海鞘的新型萜类化合物，它通过靶向细胞周期调节因子 UBE2C 来抑制肿瘤生长。
Tumor necrosis factor α-induced endoplasmic reticulum stress promotes airway smooth muscle cell proliferation.
肿瘤坏死因子α诱导的内质网应激促进气道平滑肌细胞增殖。
Circular RNA circBNC2 inhibits tumorigenesis by modulating ferroptosis and acts as a nanotherapeutic target in prostate cancer
环状 RNA circBNC2 通过调节铁死亡来抑制肿瘤发生，并作为前列腺癌的纳米治疗靶点
TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling
TRACERx 分析确定了 FAT1 通过 Hippo 信号调节染色体不稳定性和全基因组加倍的作用
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors.
综合多组学分析阐明了秋水仙碱诱导的毒性机制，并揭示了 MLN4924 和激酶抑制剂的治疗潜力
Norcantharidin promotes M1 macrophage polarization and suppresses colorectal cancer growth
去甲斑蝥素促进M1型巨噬细胞极化并抑制结直肠癌生长
Broussoflavonol B induces S-phase arrest and apoptosis in pancreatic cancer cells by modulating the cell cycle checkpoint through inhibition of the AURKA/PLK1 pathway.
Broussoflavonol B 通过抑制 AURKA/PLK1 通路调节细胞周期检查点，从而诱导胰腺癌细胞发生 S 期停滞和凋亡
ABCG8âmediated sterol efflux increases cancer cell progression via the LRP6/Wnt/βâcatenin signaling pathway in radiotherapyâresistant MDAâMBâ231 tripleânegative breast cancer cells.
ABCG8介导的甾醇外排通过LRP6/Wnt/β-catenin信号通路促进放射治疗耐药的MDA-MB-231三阴性乳腺癌细胞的癌细胞进展
Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes.
对不同放射学亚型肺腺癌中肿瘤细胞增殖（Ki-67）和细胞周期调节蛋白进行分析
- 1
- 2
- 3
- 4
- 5
- 6
- 21